Results 161 to 170 of about 3,002 (191)
Some of the next articles are maybe not open access.

Why does 4′‐nitro‐spiperone fail as precursor for the preparation of [F‐18]‐spiperone?

Journal of Labelled Compounds and Radiopharmaceuticals, 1989
M. Gvsemans, J. Mertens, W. Vanryckeghem
openaire   +1 more source

Anticancer Effects of Spiperone in C57BL/6 Mice with Emphysema and Lung Carcinoma

Bulletin of Experimental Biology and Medicine
The antitumor and antimetastatic activity of dopamine D2 receptor antagonists spiperone was studied in C57BL/6 mice in a model of combined pathology (emphysema and lung cancer). Emphysema was induced by administration of LPS and cigarette smoke extract. Lung cancer was induced by injection of Lewis lung carcinoma cells into the lung.
N N, Ermakova   +7 more
openaire   +2 more sources

Spiperone: A ligand of choice for neuroleptic receptors

Biochemical Pharmacology, 1978
Josée E. Leysen   +2 more
openaire   +1 more source

Spiperone-labelled dopamine transporter in lymphocytes

European Neuropsychopharmacology, 1992
B. Bondy   +3 more
openaire   +1 more source

Spiperone Binding in Lymphocytes: Part of a Dopamine Uptake System?

Annals of the New York Academy of Sciences, 1992
B, Bondy, M, Ackenheil, T, Ruppert
openaire   +2 more sources

Comparison of [3H]YM-09151-2 with [3H]spiperone and [3H]raclopride for dopamine D-2 receptor binding to rat striatum

European Journal of Pharmacology, 1989
Kazuyuki Hidaka   +2 more
exaly  

[3H]Spiperone binding sites in brain: autoradiographic localization of multiple receptors

Brain Research, 1981
José M Palacios   +2 more
exaly  

Elevated lymphocyte spiperone binding: A vulnerability factor for affective psychosis?

Biological Psychiatry, 1997
R, Fartaçek   +4 more
openaire   +2 more sources

Localization of [3H]spiperone binding sites in the intermediate lobe of the rat pituitary gland

Neuroscience Letters, 1982
Stephen Hunt   +2 more
exaly  

Home - About - Disclaimer - Privacy